Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Erik Ryberg"'
Autor:
Stanko Skrtic, Björn Tyrberg, Malin Broberg, Hans Ericsson, Volker Schnecke, Magnus Kjaer, Marcus Hompesch, Eva-Marie Andersson, Erik Ryberg, Alexander Aivazidis, Charlotte Wennberg Huldt, Lars Löfgren, Linda Morrow, Joanna Parkinson, Tina Rydén-Bergsten, Elaine Watkins, Maria Sörhede Winzell
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208998 (2018)
AIMS/HYPOTHESIS:GPR44 (DP2, PTGDR2, CRTh2) is the receptor for the pro-inflammatory mediator prostaglandin D2 (PGD2) and it is enriched in human islets. In rodent islets, PGD2 is produced in response to glucose, suggesting that the PGD2-GPR44/DP2 axi
Externí odkaz:
https://doaj.org/article/14eb9641fd434a2fbeda8df2991ce6e8
Autor:
Mikael Bjursell, Erik Ryberg, Tingting Wu, Peter J Greasley, Mohammad Bohlooly-Y, Stephan Hjorth
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167965 (2016)
The G-protein coupled receptor 55 (GPR55) is activated by cannabinoids and non-cannabinoid molecules and has been speculated to play a modulatory role in a large variety of physiological and pathological processes, including in metabolically perturbe
Externí odkaz:
https://doaj.org/article/9ef9d8ebdd3c4da9b9c5c9ccb034f9f0
Autor:
Yochai Birnbaum, Regina Ye, Huan Chen, Leif Carlsson, Carl Whatling, Ola Fjellström, Erik Ryberg, Yumei Ye
Publikováno v:
Cardiovascular Drugs and Therapy.
Recombinant apyrase (AZD3366) increases adenosine production and ticagrelor inhibits adenosine reuptake. We investigated whether intravenous AZD3366 before reperfusion reduces myocardial infarct size (IS) and whether AZD3366 and ticagrelor have addit
Autor:
Erik Ryberg, Simen W. Schive, David M. Smith, Shadab Abadpour, Stanko Skrtic, Tina Rydén-Bergsten, Maria Sörhede Winzell, Björn Tyrberg, Olle Korsgren, Hanne Scholz, Charlotte Wennberg Huldt, Peter Gennemark
Aims/hypothesis Inflammatory signals and increased prostaglandin synthesis play a role during the development of diabetes. The prostaglandin D2 (PGD2) receptor, GPR44/DP2, is highly expressed in human islets and activation of the pathway results in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc103a4567c7ac7049e2dca816998c4
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-166204
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-166204
Autor:
Shadab, Abadpour, Björn, Tyrberg, Simen W, Schive, Charlotte Wennberg, Huldt, Peter, Gennemark, Erik, Ryberg, Tina, Rydén-Bergsten, David M, Smith, Olle, Korsgren, Stanko, Skrtic, Hanne, Scholz, Maria Sörhede, Winzell
Publikováno v:
Diabetologia
Aims/hypothesis Inflammatory signals and increased prostaglandin synthesis play a role during the development of diabetes. The prostaglandin D2 (PGD2) receptor, GPR44/DP2, is highly expressed in human islets and activation of the pathway results in i
Autor:
Elaine Watkins, Charlotte Wennberg Huldt, Joanna Parkinson, Erik Ryberg, Volker Schnecke, Eva-Marie Andersson, Hans Ericsson, Björn Tyrberg, Marcus Hompesch, Stanko Skrtic, Tina Rydén-Bergsten, Linda Morrow, Lars Löfgren, M Kjaer, Alexander Aivazidis, Malin A. Broberg, Maria Sörhede Winzell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0208998 (2018)
PLoS ONE, Vol 13, Iss 12, p e0208998 (2018)
Aims/hypothesis GPR44 (DP2, PTGDR2, CRTh2) is the receptor for the pro-inflammatory mediator prostaglandin D2 (PGD2) and it is enriched in human islets. In rodent islets, PGD2 is produced in response to glucose, suggesting that the PGD2-GPR44/DP2 axi
Publikováno v:
Biochemical Journal
The present paper shows the non-competitive mechanism by which AZD8797 blocks fractalkine from binding and activating the CX3CR1 receptor. CX3CR1 is involved in many diseases but, lacking non-peptide ligands, it is poorly investigated. Our work can t
Autor:
Lisbeth, Kristensson, Anders, Lundin, David, Gustafsson, Jan, Fryklund, Tomas, Fex, Louise, Delsing, Erik, Ryberg
Publikováno v:
Neuroscience letters. 681
Plasminogen binding inhibitors (PBIs) reduce the risk of bleeding in hemorrhagic conditions. However, generic PBIs are also associated with an increased risk of seizures, an adverse effect linked to unwanted activities towards inhibitory neuronal rec
Autor:
Lisbeth Kristensson, Erik Ryberg, Anders Lundin, Tomas Fex, Jan Fryklund, Louise Delsing, David Gustafsson
Plasminogen binding inhibitors (PBIs) reduce the risk of bleeding in hemorrhagic conditions. However, generic PBIs are also associated with an increased risk of seizures, an adverse effect linked to unwanted activities towards inhibitory neuronal rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e987f2b8a085a5d3580804a7d3c76a5
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-15263
http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-15263
Autor:
Cherry L. Wainwright, Erik Ryberg, Christopher Lipina, Olivia Jane Robertson-Gray, Ann-Cathrine Jönsson-Rylander, Sarah K. Walsh
Publikováno v:
Pharmacology Research & Perspectives
The phospholipid l‐α‐lysophosphatidylinositol (LPI), an endogenous ligand for GPR55, is elevated in patients with acute coronary syndrome, and a GPR55 antagonist cannabidiol (CBD) reduces experimental ischemia/reperfusion (I/R) injury. While LPI